Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,714 | 2,273 | 4,555 | 2,895 | 9,070 |
| Marketable Securities | 25,042 | 31,934 | 34,489 | 37,432 | 28,413 |
| Receivables | N/A | N/A | N/A | N/A | 38 |
| TOTAL | $30,108 | $34,519 | $39,436 | $40,708 | $37,760 |
| Non-Current Assets | |||||
| PPE Net | 438 | 472 | 521 | 566 | 606 |
| Investments And Advances | 0 | 0 | 0 | 2,398 | 9,706 |
| Other Non-Current Assets | 1,540 | 1,622 | 1,704 | 1,784 | 1,860 |
| TOTAL | $1,978 | $2,094 | $2,225 | $4,748 | $12,172 |
| Total Assets | $32,086 | $36,613 | $41,661 | $45,456 | $49,932 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,715 | 847 | 1,216 | 501 | 1,034 |
| Accrued Expenses | N/A | N/A | N/A | 495 | 479 |
| TOTAL | $2,067 | $1,167 | $1,530 | $1,304 | $1,816 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,207 | 1,317 | 1,402 | 1,481 | 1,558 |
| TOTAL | $1,207 | $1,317 | $1,402 | $1,481 | $1,558 |
| Total Liabilities | $3,274 | $2,484 | $2,932 | $2,785 | $3,374 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 270 | 270 | 270 | 270 | 270 |
| Retained earnings | -119,386 | -112,912 | -106,520 | -100,340 | -94,243 |
| TOTAL | $28,812 | $34,129 | $38,729 | $42,671 | $46,558 |
| Total Liabilities And Equity | $32,086 | $36,613 | $41,661 | $45,456 | $49,932 |